CA
NZ
UK
AU
IND
US
SOPHiA GENETICS S.A. (NASDAQ:SOPH), a Swiss healthcare technology company known for its genomic data analysis platform, announced a collaboration with Myriad Genetics and AstraZeneca to advance a new prostate cancer-specific genomic instability score, called PrGIS. The biomarker is designed to assess chromosomal instability linked …
Sunshine Biopharma, Inc. (NASDAQ:SBFM), a Florida-based pharmaceutical company developing oncology and antiviral treatments alongside a portfolio of generic drugs, priced a public offering of roughly 10.9 million units at $0.55 per unit, expected to raise about $6.0 million before fees. Each unit includes one …
Viatris Inc. (NASDAQ:VTRS), a global healthcare company formed in 2020 through theMergerof Mylan and Pfizer's Upjohn division, agreed to acquire Pacira BioSciences for $36.50 per share in cash, valuing the deal at approximately $1.65 billion. TheAcquisitionwill be carried out through a tender offer followed …
● GrossMarginwidened to 58.0% from 55.2%, with Adjusted EBITDA reaching a 23.4% margin.
● Net newBusinessawards climbed 28.2% to $795.7 million, lifting book-to-bill to 1.13x.
● NoEarningsrelease, financing, regulatory development, contract news, partnership, or management change was verified behind the decline.
● NoEarningsrelease, guidance revision, downgrade, partnership, regulatory development, or management change was tied to the session.
● KAPA shares closed at $0.870 on October 7, 2026, a loss of 24.35% that erased roughly a quarter of the stock's value.
● NXTS shares closed at $1.080 on October 7, 2026, a loss of 22.30% that erased roughly a fifth of the stock's value.
● NoEarningsreport, guidance change, regulatory development, reimbursement decision, financing, or analyst action has been verified as the driver.
Please wait processing your request...